NEURONES : Croissanc
NEURONES : Croissance organique de 2,6% en 2020
February 10, 2021 11:40 ET | NEURONES
INFORMATION PRESSERubrique : C.A. annuel 2020                                                        Nanterre, le 10 février 2021 (après Bourse) Croissance organique de 2,6% en 2020 (non audités, en...
NEURONES: Organic gr
NEURONES: Organic growth up 2.6% in 2020
February 10, 2021 11:40 ET | NEURONES
PRESS INFORMATIONHeading: 2020 Annual Revenues       Nanterre, February 10, 2021 (after the closing of the stock exchange) Organic growth up 2.6% in 2020 (unaudited, in € millions)20192020Growthof...
Redevances Aurifères
Redevances Aurifères Osisko annonce la date de divulgation de ses résultats financiers pour le quatrième trimestre et l’année 2020, et les détails de la conférence téléphonique
February 04, 2021 08:18 ET | Redevances Aurifères Osisko Ltée
MONTRÉAL, 04 févr. 2021 (GLOBE NEWSWIRE) -- Redevances Aurifères Osisko Ltée (« Osisko » ou la « Société ») (TSX et NYSE : OR) annonce qu’elle publiera ses résultats financiers pour le...
20180109-ogr_200.jpg
Osisko Gold Royalties Provides Notice of Fourth Quarter and Full Year 2020 Results and Conference Call Details
February 04, 2021 08:18 ET | Osisko Gold Royalties Ltd.
MONTREAL, Feb. 04, 2021 (GLOBE NEWSWIRE) -- Osisko Gold Royalties Ltd (“Osisko” or the “Corporation”) (OR: TSX & NYSE) announces that its fourth quarter and full year 2020 results will be...
Marel: Góð rekstrarn
Marel: Góð rekstrarniðurstaða á ári samstöðu og stefnumarkandi skrefa til vaxtar
February 03, 2021 13:04 ET | Marel hf.
Marel kynnir afkomu fjórða ársfjórðungs og ársuppgjör 2020 (allar upphæðir eru í evrum) Helstu atriði: Árið 2020 – Góð rekstrarniðurstaða og stefnumarkandi skref til vaxtar Pantanir námu...
Marel: 2020 a year o
Marel: 2020 a year of unity, resilient operations and strategic moves
February 03, 2021 13:04 ET | Marel hf.
EXECUTIVE SUMMARY 2020: Resilient profitability and strategic moves Orders received were EUR 1,234.1m (2019: 1,222.1m).The order book was EUR 415.7m (3Q20: 434.3m, 4Q19: 414.4m). Revenues were...
image001.jpg
MARE NOSTRUM - Chiffre d’affaires 2020 de 123,2 M€
January 27, 2021 12:30 ET | MARE NOSTRUM
MARE NOSTRUM Accélération de la reprise au S2Chiffre d’affaires 2020 de 123,2 M€   Grenoble, le 27 janvier 2021 – 18h30 - Mare Nostrum, expert innovant des Ressources Humaines pour les PME/ETI,...
new fidelity.jpg
Fidelity D & D Bancorp, Inc. Announces First Quarter 2021 Dividend and Reports Fourth Quarter and Annual 2020 Financial Results
January 27, 2021 09:11 ET | Fidelity Deposit & Discount Bank
DUNMORE, Pa., Jan. 27, 2021 (GLOBE NEWSWIRE) -- Fidelity D & D Bancorp, Inc. (NASDAQ: FDBC) and its banking subsidiary The Fidelity Deposit and Discount Bank, announced its most recent dividend...
Bone Therapeutics fa
Bone Therapeutics fait le point sur son activité du quatrième trimestre 2020 et ses perspectives de développement pour 2021
January 20, 2021 01:00 ET | Bone Therapeutics SA
INFORMATION REGLEMENTÉE Le développement des programmes cliniques et plus particulièrement de l’essai de Phase III évaluant JTA-004 et de l’essai de Phase IIb évaluant ALLOB, se poursuit...
Bone Therapeutics pr
Bone Therapeutics provides fourth quarter 2020 business update and 2021 outlook
January 20, 2021 01:00 ET | Bone Therapeutics SA
REGULATED INFORMATION Clinical programs running on schedule, including Phase III trial of JTA-004 and Phase IIb trial of ALLOB Extensive achievements in collaborations and partnerships to...